United States

People: Koninklijke DSM NV (RDSMY.PK)

RDSMY.PK on OTC Markets Group

27 May 2016
Change (% chg)

$-0.19 (-1.26%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Doboczky, Stefan 

Mr. Stefan Doboczky has served as Member of the Managing Board of Royal DSM NV (DSM) since May 2011. Prior to joining the Company in 1998, he worked for 6 years at ARCO Chemicals in Austria and the United Kingdom. At DSM, Mr. Doboczky started in the DSM Fine Chemicals division, where he became Business Manager. In 2002 he moved to DSM Pharma Chemicals where he was Business Director from 2003 till 2006 based in the Netherlands. In 2006, he became Vice President and Business Unit Director China for DSM Anti-Infectives based in China. Since 2009 he has been Business Group Director of DSM Anti-Infectives. Since becoming a Member of the Managing Board of Koninklijke DSM NV in May 2011 he has been responsible for DSM's global activities in Pharma, as well as all DSM's activities in Asia. He is also CEO of DSM Sinochem Pharmaceutical, a joint venture between DSM and Sinochem in the area of anti-infectives. Mr. Doboczky holds a PhD degree from the University of Vienna and an MBA from IMD Business School in Lausanne, Switzerland.

Basic Compensation

Total Annual Compensation, EUR 662,175
Restricted Stock Awards, EUR --
Long-Term Incentive Plans, EUR --
All Other, EUR 17,253
Fiscal Year Total, EUR 679,428

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --